Navigation Links
Justifying the use of letrozole for inducing ovulation

Letrozole used for the treatment of advanced/metastatic breast cancer in postmenopausal women is also being used by // infertility specialists as a second line of treatment for infertility for inducing ovulation. Studies indicate that letrozole was used not on an experimental basis, but as an accepted safe drug for inducing ovulation.

However some feel that without clinical trials to ascertain any possible side effect, prescribing the drug Letrozole for infertility is unethical and illegal. Another argument is that, since the drug is used for a short duration of 5 days its effect is short acting and the side effects would be minimum or practically nil. It is also said that since the drug is administered before ovulation and fertilization, there is no question of teratogenicity (malformation of the fetus) when compared to injectible gonado tropins used for treating infertility which are associated with a higher incidence of multiple pregnancies.

It is argued that the practice of medicine is regulated by Medical Council of India, and not by the Drugs Controller hence they feel that drug controller can introduce a new drug for marketing, or ban a particular drug from being sold but should not be given the right to designate a particular drug for a particular disease, to be prescribed by a particular section of doctors.

Letrozole could be prescribed only for treating breast cancer and not for inducing ovulation as per the permission given by the Drugs Controller General of India (DCGI). However it is said that doctors cannot be asked not to prescribe it , instead ask the drug store owners not to honor any prescriptions violating existing norms stipulated by the Drugs Controller's office.

A doctor specializing in oncology and women's diseases from a city based hospital 'A cure for incurable ‘, says that the use of letrozole in a healthy women if used for ovulation may lead to developing cancer of ovary, breast or any other part of the body and the chance is one in every one thousand. Hence he concludes saying that homeopathic medicines are better alternatives for inducing ovulation as they do not have any side effect.
'"/>




Related medicine news :

1. Therapy inducing self-repair of nerves to help Alzheimer’
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2017)... ... 2017 , ... The Pennsylvania Athletic Trainers’ Society’s (PATS) Annual ... Convention Center on June 8-10. The weekend consisted of many educational presentations, ... scholarship presentations, and professional networking. , On Friday June 9th, PATS hosted ...
(Date:6/23/2017)... ... 2017 , ... The Rhode Island Quality Institute (RIQI) and ... Dashboards, an innovative new service enabling healthcare providers to proactively coordinate care and ... Dashboards provide near real-time data about patients admitted to and/or discharged from acute ...
(Date:6/23/2017)... ... ... Studies show evidence that carotenoids and antioxidants derived either from the diet or from ... how often do ophthalmologists and optometrists in Sweden recommend the use of nutritional supplements, ... symptoms of AMD? A study published recently in Dove Medical Press journal, ...
(Date:6/23/2017)... ... June 23, 2017 , ... Everybody has their own personal preference when ... read it, and some people don't like it at all. FindaTopDoc took a look ... , Erotic literature can give readers a taste of their deepest, darkest fantasies and ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia State ... 18 to 20. , The two-day conference is focused on advancing scientific knowledge ... improving patients’ lives and eliminating racial breast cancer-related disparities. The conference theme is ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 8, 2017  StatLab Medical Products ("StatLab" ... manufacturer of diagnostic supplies for the anatomic ... & Company LP ("Cressey & Company"), a ... growth-focused investment in the Company. Cressey & ... from selling shareholder, Prairie Capital, L.P., with ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... two Phase 2 trials of its RSV F protein recombinant ... bearing age have been published in the journal ... been shared in prior scientific conferences). The Company previously announced ... 2014. Novavax is developing the RSV F Vaccine with the ...
(Date:6/5/2017)... , June 5, 2017 The ... brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded ... Cincinnati Enquirer . Results are based on an ... in organizational health and workplace improvement. The survey measures several ... ...
Breaking Medicine Technology: